A look back at the National Multiple Myeloma Information Day – JNM 2022 | AF3M
On Saturday 15 October, SIRIC ILIAD was present at the National Information Day on Multiple Myeloma (JNM 2022) of the
Breast cancers: acting on cells in the tumour environment to treat the cancer?
What if acting on the cells surrounding the tumour could improve the effectiveness of treatments? On 14 September 2022, a
SIRIC ILIAD shares its research progress with its partners | SIRIC Review 2018-2022
The SIRIC ILIAD Partners Committee met on Monday 17 October 2022 to present the results of the 5 years of
General Public Conference « Living and working with cancer » INCa – 23 Nov 2022
The French National Cancer Institute is organising a day of debate and exchange for the general public on the issue
Teclistamab: a promising new treatment for multiple myeloma
Last August, Professor Philippe Moreau, haematologist and director of SIRIC ILIAD, published a scientific article in the prestigious New England
